A working demo might look promising, but it doesn't tell you whether the tech can be shipped, integrated, validated, and accepted by regulator. Tech consultant Lukasz Lazewski explains how to look past the allure and evaluate its true functionality.
- What Is Shadow AI, And How Does It Impact Clinical Trial Tech?
- Will AI And Agile Project Management Help Advance RBM?
- Building A Clinical Trial Tech Stack That Actually Works
- The Integration Dilemma: Who Decides Which Tech Stack Wins?
- Why Clinical Trial Sites Are Drowning In Tech Chaos
- The Risks And Unresolved Rules Of Real-Time Clinical Trials
- What Real-Time Clinical Trials Demand From Your Tech Stack
- The FDA's RTCT Push: What It Is; Why It Matters
ARTICLES, APP NOTES, CASE STUDIES, & WHITE PAPERS
-
Shaping The Future Of eCOA User Acceptance Testing
Proactive planning by sponsors and early User Acceptance Testing (UAT) involvement in the eCOA design process can substantially improve study quality, efficiency, and consistency.
-
From Startup To Public Company: Scaling Finance Operations
When basic tools no longer support your growing company, robust systems, such as ERPs, become essential for managing complex financial reporting, regulatory compliance, and multi-entity tracking.
-
eReg Benefits For Clinical Research: Use Cases For All Types Of Sites
Unearth the different kinds of eRegulatory use cases for diverse clinical site types and other eRegulatory capabilities designed to serve all sites.
-
What Are Decentralized Clinical Trials (DCTs)?
Discover how DCTs leverage “virtual” tools, such as telemedicine, sensory-based technologies, wearable medical devices, and direct delivery of study drugs and materials to patients’ homes.
-
12 Items Auditors Look For When Reviewing An Investigator Site File
Maintaining complete, compliant documentation on top of managing the complex processes and interactions of clinical trial conduct can be challenging. Explore twelve items to help you prepare your ISF for an audit.
-
How Efficiencies In Trial Builds Facilitate Quicker Data Collection
Discover how the integration of EDC technology benefits researchers and can hasten treatment and therapy development, improving the lives of patients.
-
AI, Virtual Participants, and the Evolving FDA Regulatory Landscape
Understanding emerging requirements around transparency, risk, and governance is essential for responsibly advancing AI-driven innovation in regulated environments.
-
The TMF Trifecta: Finding Balance In An Era Of Constant Change
In this article, discover TMF through the operational framework of people, process, and technology and how these factors affect stakeholders.
-
Key CTMS Capabilities To Improve Financial Management
In clinical research, utilizing your clinical trial management system (CTMS) to its fullest potential can allow for more streamlined financial management, visit management, compliance, patient recruitment, and more. This blog outlines what you should look for in a CTMS to maximize your organization’s return on investment (ROI).
-
Focusing On Patient-Reported Outcome Measures And eConsent
Learn how digital solutions can contribute to a more participant-centered approach and potentially enhance the regulatory utility of PRO data while improving the overall quality and efficiency of oncology trials.
RECENT NEWSLETTERS
- 07.09.26 -- AI Governance, Real-Time Trials, And Hidden Risks to Watch
- 07.03.26 -- Best Of June: AI, Data, And What's Fixing Trial Execution
- 07.02.26 -- How AI And Real-Time Tech Are Changing Trial Execution
- 06.25.26 -- How AI, Data, And Workflows Are Fixing Trial Execution
- 06.18.26 -- AI, eSource, And Site Tech: What's Actually Working In Trials